divislab glp-1 novo nordisk relation A $60 billion industry just found its next growth lever. 💊 With the expiry of a key patent on March 20, 2026, Indian pharma majors are launching generic weight-loss and diabetes drugs Understanding GLP-1 in Diabetes

Protein + Fiber Balance Very low food intake can worsen constipation

ODonoghue G, Blake C, Cunningham C, Lennon O, Perrotta C

Berberine, the primary named active ingredient in LeviaPatch, has a meaningful research record in metabolic health - oral berberine studies have documented modest reductions in body weight, BMI, and blood glucose markers

If Tirzepatide is a good fit, the clinic designs a personalized plan that typically includes a starting dose of the injection with a schedule for gradual adjustment, education on proper injection technique and safe handling of the medication, and a realistic nutrition strategy focused on balanced meals with adequate protein, fiber, and hydration

A., Jimeno, J., and Raymond, E